NCT Number: NCT02309749
CAP Pilot Study for Obstructive Sleep Apnea (OSA)
This is a pilot to review the feasibility of a program that assists patients towards therapy compliance by scheduled intervention through the first month of therapy. The hypothesis of this study is that the trial program will function as intended and average patient adherence will be over 4 hours per night.
Looking for future studies?
Notify MeKey information
Conditions
Age range
21 year–75 year
Sex eligibility
All sexes
Study type
Observational
Primary location
Clayton Sleep Institute, St Louis, Missouri, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- 21 to 75 years of age
- Diagnosed with OSA (AHI >5 events/hour) and eligible for Continuous Positive Airway Pressure (CPAP) treatment under local requirements
- Must be initiated on program (i.e. received their device) within 12 weeks of CPAP titration study
- Naïve to CPAP therapy, i.e have not been prescribed CPAP in the past
- Access to a cellphone
Exclusion criteria
- Contraindicated for CPAP therapy
- Medically unstable condition/diagnosis that is not yet under control
- Co-existing sleep disorder (however clinically diagnosed insomnia can be included in the study)
- Periodic Leg MOvement Arousal Index greater than 15/hr
- Home titration of longer than 5 days
Treatment and study plan
Primary outcomes
-
Accuracy of delivery of SMS messages to participant
Time frame: 30 days
Cross check recieved messages logged in a diary by the participant to those sent by CAP
Secondary outcomes
-
Participant CPAP Adherence
Time frame: 30 nights
Assess the adherence of participants to CPAP therapy while enrolled in CAP
Sponsors and collaborators
Lead sponsor
Fisher and Paykel Healthcare
Industry
Registry information
Important dates
- Study start
- 2013
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Dec 5, 2014
- Registry last updated
- Dec 8, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
NCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsRePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA
NCT06146101
Apnea, Dyssomnias
Chula Vista, California, United States
View Trial DetailsDISE vs Muller's Maneuver in OSA Assessment
NCT07723417
Apnea, Dyssomnias
Al Mansurah, Dakahlia Governorate, Egypt
View Trial DetailsTreating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation
NCT04950894
Apnea, Apnea+Hypopnea
Birmingham, Alabama, United States
View Trial Details